Press Releases
Abionic Appoints Patrick Pestalozzi as New CEO to Propel Company into Next Growth Phase

Biopôle, Lausanne, Switzerland, February 22, 2024 – Abionic SA, a Swiss leader in nanofluidic point-of-care diagnostic solutions, is thrilled to announce the appointment of Patrick Pestalozzi as its new Chief Executive Officer, effective April 1st, 2024.

A former Management Consultant, Silicon Valley executive, and Entrepreneur, Patrick brings to Abionic 3 decades of global experience, more recently as the Vice-President of Global Strategic Accounts for Mindmaze (Digital Neuro DTx) and Managing Director (CEO) at GaitUp, a Mindmaze subsidiary, where he spearheaded efforts to scale its business capability and drive international expansion.

A Senior Executive & Adviser to early-stage and mature organisations, Patrick is actively involved in the creation, financing, and development of multiple science-based, deep-tech ventures. His hands-on experience in managing P&L, driving growth strategies, and leading organisational design and product management across different Healthcare verticals and geographies, positions him as the ideal leader to steer Abionic through its next development cycle.

"We are excited to welcome Patrick Pestalozzi to the Abionic team," said Dr. Nicolas Durand, Founder and CEO of Abionic for 14 years. "His exceptional track record, deep understanding of the healthcare and technology sectors, and visionary leadership style are precisely what Abionic needs as we embark on our ambitious journey to redefine diagnostic standards and expand our global footprint."

Patrick's appointment marks a significant milestone in Abionic's development journey as it aims for market leadership in the field of Sepsis diagnostics. The entire Abionic team looks forward to working under Patrick's leadership to greatly enhance the company's ability to bring ground-breaking diagnostic solutions to market and spearhead its US expansion.

Abionic's Board of Directors would like to express its gratitude and praise Nicolas for his sharp vision and effective leadership managing the company he co-founded 14 years ago. Nicolas will continue to serve the company as a key member of the Board of Directors.


About Abionic

Founded in 2010, Abionic is a Swiss-based medical technology company dedicated to transforming the landscape of healthcare diagnostics through rapid, point-of-care solutions. Leveraging cutting-edge nanotechnology, Abionic's platform offers healthcare professionals and patients with immediate and accurate diagnostic results, facilitating quicker decision-making and improved patient outcomes.

For further information about Abionic, please visit